4527 ROHTO PHARMACEUTICAL CO.,LTD.ロート製薬TSE Prime / Pharmaceuticals
0 posts
ROHTO PHARMACEUTICAL CO.,LTD. (4527) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
ROHTO PHARMACEUTICAL CO.,LTD. (4527) Stock Price History
ROHTO PHARMACEUTICAL CO.,LTD. closed at ¥2,632 on Nov 20, 2026, −9.7% over 1 month, +6.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥90,336 today (−9.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −9.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,632 | −30 | −1.13% |
| Nov 19 (Thu) | ¥2,662 | +18.5 | +0.70% |
| Nov 18 (Wed) | ¥2,643 | −11 | −0.41% |
| Nov 17 (Tue) | ¥2,654 | +70 | +2.71% |
| Nov 16 (Mon) | ¥2,584 | +138.5 | +5.66% |
| Nov 13 (Fri) | ¥2,446 | −241 | −8.97% |
| Nov 12 (Thu) | ¥2,687 | +57.5 | +2.19% |
| Nov 11 (Wed) | ¥2,629 | −133 | −4.82% |
| Nov 10 (Tue) | ¥2,762 | −18 | −0.65% |
| Nov 9 (Mon) | ¥2,780 | +84 | +3.12% |
If you had invested ¥100,000 3 months ago, it would be worth ¥91,786 today (−8.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −8.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,632 | −30 | −1.13% |
| Nov 19 (Thu) | ¥2,662 | +18.5 | +0.70% |
| Nov 18 (Wed) | ¥2,643 | −11 | −0.41% |
| Nov 17 (Tue) | ¥2,654 | +70 | +2.71% |
| Nov 16 (Mon) | ¥2,584 | +138.5 | +5.66% |
| Nov 13 (Fri) | ¥2,446 | −241 | −8.97% |
| Nov 12 (Thu) | ¥2,687 | +57.5 | +2.19% |
| Nov 11 (Wed) | ¥2,629 | −133 | −4.82% |
| Nov 10 (Tue) | ¥2,762 | −18 | −0.65% |
| Nov 9 (Mon) | ¥2,780 | +84 | +3.12% |
If you had invested ¥100,000 6 months ago, it would be worth ¥103,379 today (+3.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +3.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,632 | −4.0% |
| Oct 2026 | ¥2,740 | −2.5% |
| Sep 2026 | ¥2,809 | −8.1% |
| Aug 2026 | ¥3,055 | +27.9% |
| Jul 2026 | ¥2,389 | +0.1% |
| Jun 2026 | ¥2,387 | +0.3% |
| May 2026 | ¥2,381 | +3.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥106,023 today (+6.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +6.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,632 | −4.0% |
| Oct 2026 | ¥2,740 | −2.5% |
| Sep 2026 | ¥2,809 | −8.1% |
| Aug 2026 | ¥3,055 | +27.9% |
| Jul 2026 | ¥2,389 | +0.1% |
| Jun 2026 | ¥2,387 | +0.3% |
| May 2026 | ¥2,381 | +3.5% |
| Apr 2026 | ¥2,301 | −4.4% |
| Mar 2026 | ¥2,408 | −1.4% |
| Feb 2026 | ¥2,442 | −4.5% |
| Jan 2026 | ¥2,558 | −2.7% |
| Dec 2025 | ¥2,628 | +3.9% |
| Nov 2025 | ¥2,531 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥82,106 today (−17.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −17.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,632 | +0.1% |
| 2025 | ¥2,628 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥156,870 today (+56.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +56.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,632 | +0.1% |
| 2025 | ¥2,628 | ― |
If you had invested ¥100,000 in Feb 2001, it would be worth ¥885,282 today (+785.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved +785.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,632 | +0.1% |
| 2025 | ¥2,628 | −8.7% |
| 2024 | ¥2,878 | +1.2% |
| 2023 | ¥2,843 | +22.5% |
| 2022 | ¥2,320 | +33.5% |
| 2021 | ¥1,738 | +13.7% |
| 2020 | ¥1,528 | −8.0% |
| 2019 | ¥1,660 | +10.7% |
| 2018 | ¥1,500 | −0.3% |
| 2017 | ¥1,505 | +63.8% |
| 2016 | ¥919 | −24.1% |
| 2015 | ¥1,211 | +60.9% |
| 2014 | ¥753 | −6.2% |
| 2013 | ¥803 | +59.4% |
| 2012 | ¥504 | +1.7% |
| 2011 | ¥495 | +4.3% |
| 2010 | ¥475 | −11.3% |
| 2009 | ¥535 | −13.9% |
| 2008 | ¥622 | −0.3% |
| 2007 | ¥624 | +1.5% |
| 2006 | ¥614 | +3.8% |
| 2005 | ¥592 | +75.1% |
| 2004 | ¥338 | +51.1% |
| 2003 | ¥224 | +10.0% |
| 2002 | ¥203 | +10.0% |
| 2001 | ¥185 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2001). Please check the latest prices before trading.
ROHTO PHARMACEUTICAL CO.,LTD. (4527) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of ROHTO PHARMACEUTICAL CO.,LTD. (4527)
Business overview
Together with 115 subsidiaries and 18 affiliates, the company makes and sells products and services mainly in health and beauty care: eye care (eye drops, eye washes and more), skin care (topical drugs, lip balm, sunscreen, functional cosmetics and more), oral and food products (gastrointestinal medicines, Kampo medicines, supplements and more), medical (CDMO business, prescription ophthalmic drugs and more) and others (in vitro diagnostics and more). Its segments are regional: Japan, the Americas, Europe and Asia. In Japan the company handles all fields, with 「ロートニッテン」 and 「クオリテックファーマ」 handling medical products. In the Americas and Europe, Mentholatum and others make and sell mainly skin care products, and in Asia, Mentholatum Asia Pacific and others make and sell mainly eye care and skin care products.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 1.90% | No. 31 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 16.8x | Above the sector median of 16.5x (No. 18 from the lowest) |
| PBR | 1.88x | Above the sector median of 1.86x (No. 39 from the lowest) |
| ROE | 11.17% | No. 11 in the sector (highest first); median 4.17% |
| Market cap | ¥591.9 bn | No. 12 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥3,106 | 8/28 |
|---|---|---|
| 52-week low | ¥2,251 | 3/5 |
| Current position | 44.5% | Where the low is 0% and the high is 100% (close on 11/20: ¥2,632) |
| Year to date | +0.1% | No. 17 of 77 in the sector (best first) |
| 1 year | +6.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 losers | 1 times | Latest: 11/13 (No. 35) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/12 15:302027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/12 15:302027年3月期第2四半期(中間期) 決算説明会
- 10/05 14:00「中長期成長戦略2026」の一部訂正に関するお知らせ
- 10/05 14:00「中長期成長戦略2026」1005訂正版
- 10/02 10:00「中長期成長戦略2026」
- 10/02 10:00経営戦略説明会資料
Filings from the past 12 months (6).
Shareholder benefits of ROHTO PHARMACEUTICAL CO.,LTD.
Details and disclosure history of ROHTO PHARMACEUTICAL CO.,LTD.'s shareholder benefits
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the ROHTO PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- ONO PHARMACEUTICAL CO.,LTD.4528
- iShares S&P 500 Premium Income ETF452A
- Yuki Gosei Kogyo Co.,Ltd.4531
- Mochida Pharmaceutical Co.,Ltd.4534
- SANTEN PHARMACEUTICAL CO.,LTD.4536
- Fuso Pharmaceutical Industries,Ltd.4538
- NIPPON CHEMIPHAR CO.,LTD.4539
- iShares 20+ Year US Treasury Bond Premium Income ETF453A
- TSUMURA & CO.4540
- TERUMO CORPORATION4543
- H.U. Group Holdings,Inc.4544
- KISSEI PHARMACEUTICAL CO.,LTD.4547